Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Diomed Developments Limited, T/A Dermal Laboratories, Tatmore Place, Gosmore, Hitchin, Herts, SG4 7QR, UK
For the topical treatment of dermatoses of the scalp, such as psoriasis and seborrhoeic dermatitis, which are unresponsive to less potent corticosteroids.
For adults, including the elderly, and children over the age of one year: Betacap Scalp Application should be applied sparingly to the scalp night and morning until improvement is noticeable. It may then be possible to sustain improvement by applying once a day, or less frequently.
For the treatment of seborrhoeic dermatitis in children, the product should not be used for longer than 5 to 7 days.
Acute overdosage is very unlikely to occur. However, in the case of chronic overdosage or misuse, the features of hypercorticism may appear and in this situation treatment with Betacap Scalp Application should be discontinued.
3 years.
Do not store above 25°C. Protect from light. Return bottle to carton between use.
30 ml and 100 ml polyethylene squeeze bottle with integral nozzle/applicator for convenient direct application to the scalp through the hair, and tamper-evident replaceable cap.
Not applicable.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
